Design Therapeutics to Participate in Leerink’s Global Healthcare Conference
Provided By GlobeNewswire
Last update: Mar 3, 2025
CARLSBAD, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat during Leerink’s Global Healthcare Conference on Monday, March 10, 2025, at 1:40 p.m. ET in Miami.
Read more at globenewswire.com
